DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr | ₹4,596 Cr | ₹3,851 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹5,785 Cr |
Mar2023 | ₹5,113 Cr |
Mar2022 | ₹5,009 Cr |
Mar2021 | ₹4,596 Cr |
Mar2020 | ₹3,851 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹5,785 Cr | 13.14 | |
Mar2023 | ₹5,113 Cr | 2.08 | |
Mar2022 | ₹5,009 Cr | 8.97 | |
Mar2021 | ₹4,596 Cr | 19.34 | |
Mar2020 | ₹3,851 Cr | - |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹153,275.8 Cr | -2.3% | 0.8% | 72.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,393.0 Cr | -2.8% | 7.6% | 8.4% | Stock Analytics | |
CIPLA | ₹116,434.0 Cr | -5.4% | -1.5% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,474.0 Cr | -0.8% | 6.8% | 25.6% | Stock Analytics | |
MANKIND PHARMA | ₹99,974.0 Cr | 2.1% | 3.7% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,465.9 Cr | -5.5% | 1.6% | -5.1% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -2.3% |
0.8% |
72.7% |
SENSEX | 0.7% |
4% |
6.3% |
You may also like the below Video Courses